Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

CM Alvim Impl Ti 3.5X13: medical device reports filed with FDA

1,195 reports name it, 2017–2026. Manufacturer given most often on reports: Jjgc. Product code DZE.

1,195
device reports naming the brand
0% of all MAUDE reports · about 138 a year
76
reports, 12 months to August 2026
168 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

1,195 medical device reports received by FDA name the brand "CM Alvim Impl Ti 3.5X13" (endosseous dental implant); the manufacturer given most often on reports is Jjgc; received from November 2017 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

76 reports arrived in the 12 months to August 2026, down 55% from 168 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (86.8%), loss of osseointegration (6.9%) and fracture (1.5%). The patient problems coded most often are pain, fibrosis and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

053105Sep 2021: 4Oct 2021: 3Nov 2021: 5Dec 2021: 62022Jan 2022: 7Feb 2022: 4Mar 2022: 7Apr 2022: 11May 2022: 20Jun 2022: 17Jul 2022: 22Aug 2022: 44Sep 2022: 27Oct 2022: 88Nov 2022: 39Dec 2022: 112023Jan 2023: 105Feb 2023: 17Mar 2023: 21Apr 2023: 63May 2023: 12Jun 2023: 22Jul 2023: 5Aug 2023: 23Sep 2023: 6Oct 2023: 11Nov 2023: 17Dec 2023: 42024Jan 2024: 2Feb 2024: 5Mar 2024: 5Apr 2024: 7May 2024: 6Jun 2024: 18Jul 2024: 44Aug 2024: 100Sep 2024: 39Oct 2024: 40Nov 2024: 16Dec 2024: 152025Jan 2025: 13Feb 2025: 7Mar 2025: 9Apr 2025: 0May 2025: 0Jun 2025: 20Jul 2025: 8Aug 2025: 1Sep 2025: 3Oct 2025: 20Nov 2025: 8Dec 2025: 62026Jan 2026: 8Feb 2026: 4Mar 2026: 5Apr 2026: 8May 2026: 1Jun 2026: 2Jul 2026: 8Aug 2026: 3

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01533062017: 720172018: 420182019: 2420192020: 6220202021: 6420212022: 29720222023: 30620232024: 29720242025: 9520252026: 392026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%1,195
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report98%1,171
Voluntary report0%0
User facility report0%0
Distributor report2%24
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate1,03786.8%62.8%
Loss of osseointegration836.9%22.4%
Fracturea broken bone181.5%1.6%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Painpain, site not specified12810.7%
Fibrosis766.4%
Tissue damage463.8%
Hemorrhage/blood loss/bleeding292.4%
Swelling/ edema262.2%
Fistula252.1%
Inflammationinflammation181.5%
Failure of implant30.3%
Abscessa collection of pus10.1%
Swellingswelling10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureCM Alvim Impl Ti 3.5X13Product code DZEAll MAUDE reports
Reports1,1953,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer98%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about CM Alvim Impl Ti 3.5X13 reports

How many FDA reports name CM Alvim Impl Ti 3.5X13?

1,195 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 76 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (86.8%), loss of osseointegration (6.9%) and fracture (1.5%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (98%) and distributor reports (2%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that CM Alvim Impl Ti 3.5X13 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.